Drugs A - Z
Generic Name: lactobacillus acidophilus | Brand Name: Flora-Q
CategoryHerbs & Supplements
Acidophilus, Acidophilus Extra Strength®, acidophilus milk, Actilact, Actimel®, Bacid®, Cultura®, DDS-Acidophilus, Endolac®, Enpac®, Fermalac® (Canadian), Florajen®, fresh poi, Gynoflor®, Infloran®, Kala®, Kyo-Dophilus®, L-92, Lacteol Fort®, lactic acid bacteria mixture (Oxadrop), lactic acid-producing bacteria (LAB), Lactinex®, Lactobacillaceae (family), lactobacilli, lactobacillus, Lactobacillus acidophilus 145, Lactobacillus acidophilus DDS-1, Lactobacillus acidophilus LA 02, Lactobacillus acidophilus La5, Lactobacillus acidophilus L-92, Lactobacillus acidophilus milk, Lactobacillus acidophilus NCFM, Lactobacillus acidophilus OLL2769, Lactobacillus acidophilus NCK56, Lactobacillus acidophilus strain 27L, Lactobacillus acidophilus strain LB (LaLB), Lactobacillus acidophilus yogurt, Lactobacillus LB, Lacto Bacillus, MoreDophilus®, Narine®, poi, Probiata®, Pro-Bionate®, probiotic, sour poi, Superdophilus®, yogurt.
Lactobacilli are bacteria that normally live in the human small intestine and vagina. Lactobacillus acidophilus is generally considered to be beneficial because it produces vitamin K, lactase, and anti-microbial substances such as acidolin, acidolphilin, lactocidin, and bacteriocin. Multiple human trials report benefits of Lactobacillus acidophilus for bacterial vaginosis. Other medicinal uses of Lactobacillus acidophilus are not sufficiently studied to form clear conclusions.
The term "probiotic" is used to describe organisms that are used medicinally, including bacteria such as Lactobacillus acidophilus and yeast such as Saccharomyces boulardii.
Although generally believed to be safe with few side effects, Lactobacillus acidophilus taken by mouth should be avoided in people with intestinal damage, a weakened immune system, or with overgrowth of intestinal bacteria.
EvidenceDISCLAIMER: These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.
Multiple human studies report thatLactobacillus acidophilusvaginal suppositories are effective in the treatment of bacterial vaginosis. A small number of studies suggest that eating yogurt enriched withLactobacillus acidophilusmay be similarly beneficial. Additional research is necessary before a firm conclusion can be reached. Patients with persistent vaginal discomfort are advised to seek medical attention.
Allergic disorders (Japanese cedar pollen):
A small study was conducted to evaluate the effects ofLactobacillus acidophilusstrain L-92 (L-92) on the symptoms of Japanese cedar pollen allergy. Further research is needed before a decision can be made.
There is limited research in this area with unclear results.
There is currently not enough evidence to suggest a benefit ofLactobacillus acidophilusfor this condition.
Early studies in humans have failed to show a consistent benefit ofLactobacillus acidophilusin breast cancer. Further studies are needed.
Colitis (collagenous colitis):
Early studies fail to show a benefit ofLactobacillus acidophilusin this condition. More high-quality studies are needed.
A small amount of human research suggests thatLactobacillus acidophilusmay not be effective when used to prevent diarrhea in travelers or in people taking antibiotics, but results are mixed. Several studies report that the related species,LactobacillusGG, may be helpful for the prevention of diarrhea in children and travelers. Additional study is needed in these areas before a firm conclusion can be drawn.
Diarrhea treatment (children):
A small amount of research in children, using different forms of acidophilus, reports no improvement in diarrhea. Future studies should use a viableLactobacillus acidophilusculture to assess effects on diarrhea.LactobacillusGG, a different species, is suggested by multiple human studies to be a safe and effective treatment for diarrhea in otherwise healthy infants and children.
Lactobacillus acidophilusmay aid in the management of chronic or persistent diarrhea, bacterial-overgrowth related diarrhea, and acute watery diarrhea in infants. Further research is needed to determine what dose may be safe and effective.
H. pylori infection:
Early studies in humans suggest a potential benefit ofLactobacillus acidophilusin this condition. More large, high-quality studies are needed to understand this relationship.
There is conflicting information from several human studies regarding the effects ofLactobacillus acidophilus-enriched dairy products on lowering blood levels of total cholesterol or low-density lipoprotein ("bad cholesterol").
Early studies fail to show consistent evidence of benefit ofLactobacillus acidophilusin immunomodulation. Additional studies are needed.
Intestinal blockage (partial adhesive small-bowel obstruction):
Early studies suggest potential benefit of adjunct therapy withLactobacillus acidophilusin this condition. Additional high-quality studies are needed.
Intestinal inflammation (pouchitis):
Early studies in humans have failed to show a benefit ofLactobacillus acidophilusin this condition. More studies are needed.
Irritable bowel syndrome:
Human studies report mixed results in the improvement of bowel symptoms after takingLactobacillus acidophilusby mouth.
There is conflicting information from several human studies as to whether usingLactobacillus acidophilusby mouth improves digestion of lactose. More research is needed in this area a before a conclusion can be drawn.
Leaky gut syndrome (gut barrier function):
Early human studies suggest potential benefit ofLactobacillus acidophilusin the improvement of gut barrier function. More high-quality studies are needed to understand this relationship.
Necrotizing enterocolitis prevention in infants:
One human study usingLactobacillus acidophilusin combination with another bacterium (Bifidobacterium infantis) in infants reported fewer cases of necrotizing enterocolitis (severe inflammation of the gut), and no complications related to treatment. Additional research is necessary in this area before a conclusion can be drawn.
Premature birth prevention:
Early studies suggest a potential benefit ofLactobacillus acidophilusfor prevention of premature birth. More studies are needed to clarify this relationship.
Vaginal candidiasis (yeast infection):
Lactobacillus acidophilustaken by mouth or as a vaginal suppository has not been adequately assessed for the prevention or treatment of vaginal yeast infections. More research is needed in this area a before a strong conclusion can be drawn.
TraditionWARNING: DISCLAIMER: The below uses are based on tradition, scientific theories, or limited research. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. There may be other proposed uses that are not listed below.
Adults (18 years and older)
Expert opinion suggests that a dose between 1 and 10 billion viable (live) Lactobacillus acidophilus bacteria taken daily in divided doses by mouth is sufficient for most people. Higher doses may cause mild abdominal discomfort, and smaller doses may not be able to establish a stable population in the gut. For vaginal bacterial infections, a dose that has been used is 8 ounces of yogurt containing Lactobacillus acidophilus in a concentration of 100 million colony-forming units (108 CFU) in each milliliter. Capsules containing 1.5 grams of Lactobacillus acidophilus were used in one study.
Doses that have been used for vaginal infections include 1 to 2 tablets (containing 10 million to 1 billion CFU in each tablet), inserted into the vagina once or twice daily. Capsules containing 1.5 grams of Lactobacillus acidophilus have been used to treat diarrhea as anal suppositories.
Children (younger than 18 years)
Some natural medicine textbooks and experts suggest that one-quarter teaspoon or one-quarter capsule of commercially available Lactobacillus acidophilus may be safe for use in children for the replacement of gut bacteria destroyed by antibiotics. Up to 12 billion lyophilized heat-killed Lactobacillus acidophilus has been given every 12 hours by mouth for up to five days. It is often recommended that Lactobacillus acidophilus supplements be taken two hours after antibiotic doses because antibiotics may kill Lactobacillus acidophilus if taken at the same time. Consult a qualified healthcare practitioner prior to using Lactobacillus acidophilus in children, and use cautiously in those under three years of age.
Liquid preparations have been used on the diaper area to treat yeast infections, although safety and effectiveness are not well studied. Consult a qualified healthcare practitioner prior to using Lactobacillus acidophilus in children, and use cautiously in those under three years of age.
SafetyDISCLAIMER: Many complementary techniques are practiced by healthcare professionals with formal training, in accordance with the standards of national organizations. However, this is not universally the case, and adverse effects are possible. Due to limited research, in some cases only limited safety information is available.
Lactose sensitive people may develop abdominal discomfort from dairy products containing Lactobacillus acidophilus.
Side Effects and Warnings
Studies report few side effects from Lactobacillus acidophilus when used at recommended doses. The most common complaint is abdominal discomfort or gas, which usually resolves with continued use. Some experts recommend limiting the daily dose of living Lactobacillus acidophilus organisms to reduce the risk of abdominal discomfort. Some women have reported burning of the vagina after using Lactobacillus acidophilus vaginal tablets.
There are rare reports of infections of heart valves with Lactobacillus acidophilus, and the risk may be greater in people with artificial heart valves. People with severely weakened immune systems (due to disease or drugs like cancer chemotherapy and organ transplant immunosuppressants) may develop serious infections or bacteria in the blood from taking Lactobacillus acidophilus. Therefore, Lactobacillus acidophilus should be avoided in such individuals. People with intestinal damage or recent bowel surgery should avoid taking lactobacilli.
Pregnancy and Breastfeeding
There is not enough scientific study available to establish safety during pregnancy. Therefore, pregnant women should use Lactobacillus acidophilus cautiously and under medical supervision, if at all. A small number of pregnant women have taken part in studies investigating Lactobacillus acidophilus vaginal tablets and a culture of Lactobacillus acidophilus with no negative effects reported. Further research is necessary.
Interactions with Drugs
Some experts believe that Lactobacillus acidophilus taken by mouth should be used two to three hours after antibiotic doses, to prevent killing the Lactobacillus acidophilus. It has also been suggested that lactobacilli are damaged by alcohol and should not be taken at the same time. Scientific research is limited in these areas.
In theory, Lactobacillus acidophilus taken by mouth might not survive the acidic environment of the stomach. Some experts have suggested that antacids should be taken 30 to 60 minutes before taking lactobacilli. However, this has not been well studied in humans.
In theory, Lactobacillus acidophilus may prolong the effects of some drugs, including birth control pills, the contraceptive vaginal ring, or benzodiazepines such as diazepam (Valium®). Based on laboratory experiments, Lactobacillus acidophilus may reduce the effectiveness of sulfasalazine (Azulfidine®), a drug used for inflammatory bowel disease.
Interactions with Herbs and Dietary Supplements
Fructo-oligosaccharides (FOS, also called "prebiotics") are non-digestible sugar chains that are nutrients for lactobacilli. Some experts believe that FOS, taken by mouth, may help the growth of lactobacilli. Natural food sources of FOS include banana, Jerusalem artichoke, onion, asparagus, and garlic.
Lactobacillus casei, Saccharomyces boulardi, or other probiotics may add to the effects of Lactobacillus acidophilus.
This information is based on a professional level monograph edited and peer-reviewed by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com): Ethan Basch, MD, MPhil, MSc (Memorial Sloan-Kettering Cancer Center); Dawn Costa, BA, BS (Natural Standard Research Collaboration); Ron Dixon, MD (Massachusetts General Hospital); Jenna Hollenstein, MS, RD (Natural Standard Research Collaboration); Carolyn Williams Orlando, MA (American Botanical Council); David Sollars, MAc, HMC (Merrimack College); Shaina Tanguay-Colucci, BS (Natural Standard Research Collaboration); Catherine Ulbricht, PharmD (Massachusetts General Hospital); Mamta Vora, PharmD (Northeastern University); Lisa Wendt, PharmD (Albany College of Pharmacy); Wendy Weissner, BA (Natural Standard Research Collaboration).
BibliographyDISCLAIMER: Natural Standard developed the above evidence-based information based on a thorough systematic review of the available scientific articles. For comprehensive information about alternative and complementary therapies on the professional level, go to www.naturalstandard.com. Selected references are listed below.
Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999;104(5):e64.
Delia A, Morgante G, Rago G, et al. Effectiveness of oral administration of Lactobacillus paracasei subsp. Paracasei F19 in association with vaginal suppositories of Lactobacillus acidofilus in the treatment of vaginosis and in the prevention of recurrent vaginitis. Minerva Ginecol 2006 Jun;58(3):227-31.
dios Pozo-Olano J, Warram JH, Jr., Gomez RG, et al. Effect of a lactobacilli preparation on traveler's diarrhea. A randomized, double blind clinical trial. Gastroenterology 1978;74(5 Pt 1):829-830.
Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm.Bowel Dis 2004;10(3):286-299.
Gotteland M, Poliak L, Cruchet S, et al. Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori. Acta Paediatr 2005 Dec;94(12):1747-51.
Hilton E, Isenberg HD, Alperstein P, et al. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992;116(5):353-357.
Ishida Y, Nakamura F, Kanzato H, et al. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study. J Dairy Sci 2005;88(2):527-533.
Kliegman RM, Willoughby RE. Prevention of necrotizing enterocolitis with probiotics. Pediatrics 2005;115(1):171-172.
Saggioro, A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 2004;38(6 Suppl):S104-S106.
Salazar-Lindo E, Figueroa-Quintanilla D, et al.. Effectiveness and safety of Lactobacillus LB in the treatment of mild acute diarrhea in children. J Pediatr Gastroenterol Nutr 2007 May;44(5):571-6.
Saltzman JR, Russell RM, Golner B, et al. A randomized trial of Lactobacillus acidophilus BG2FO4 to treat lactose intolerance. Am J Clin Nutr 1999;69(1):140-146.
Sazawal S, Hiremath G, Dhingra U, et al. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006 Jun;6(6):374-82.
Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007 Jan;119(1):184-91.
Vivatvakin B, Kowitdamrong E. Randomized control trial of live Lactobacillus acidophilus plus Bifidobacterium infantis in treatment of infantile acute watery diarrhea. J Med Assoc Thai 2006 Sep;89 Suppl 3:S126-33.
Xiao SD, Zhang de Z, Lu H, et al. Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Adv Ther 2003;20(5):253-260.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.